Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5105 studies found for:    University of Maryland, Baltimore
Show Display Options
Rank Status Study
21 Completed
Has Results
Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4
Condition: Type 2 Diabetes
Intervention: Other: Hyperinsulinemic Hypoglycemic Clamp
22 Active, not recruiting Duloxetine for the Treatment of Chronic Pelvic Pain
Condition: Pelvis Pain Chronic
Interventions: Drug: Duloxetine;   Drug: Placebo
23 Recruiting Differing Levels of Hypoglycemia
Condition: Hypoglycemia
Intervention: Device: Glucose clamp
24 Unknown  Benefits of Universal Glove and Gowning
Conditions: MRSA;   VRE
Intervention:
25 Recruiting Face Transplantation
Condition: Transplantation: Facial Transplantation
Intervention: Procedure: Face Transplant
26 Terminated A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
Condition: Cirrhosis
Intervention: Drug: IV bolus injection of Sildenafil
27 Recruiting Transdermal Patch CVD 2000: The Effect of Heat on Fentanyl Release From Fentanyl Patches in Healthy Adults
Condition: Peer Review, Research
Interventions: Drug: Duragesic Reference Fentanyl Patch;   Drug: Apotex Generic Fentanyl Patch;   Drug: Mylan Generic Fentanyl Patch
28 Completed Transdermal Patch CVD 1000: The Effect of Heat on Nicotine Release From Nicotine Patches in Adult Smokers
Condition: Smoking
Interventions: Drug: Nicoderm CQ patch;   Drug: Aveva nicotine patch
29 Completed Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia
Conditions: Schizophrenia;   Obesity
Intervention:
30 Completed Genetic Analysis of African-Americans With High Blood Pressure
Condition: Hypertension
Intervention:
31 Unknown  Imaging of Traumatic Brain Injury
Condition: Traumatic Brain Injury
Intervention:
32 Unknown  Tailored Messages to Increase Eye Examination Behavior
Conditions: Eye Disease;   Eye Care
Interventions: Behavioral: tailored newsletter;   Behavioral: targeted newsletter
33 Withdrawn Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM
Condition: Type 2 Diabetes
Interventions: Drug: Pramlintide acetate;   Drug: Placebo
34 Unknown  Integrative Meditation (IM) for Cocaine Addiction
Condition: Cocaine Addiction
Interventions: Behavioral: Integrative Meditation;   Behavioral: Supportive Counseling
35 Completed Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Atomoxetine
36 Unknown  R5 Integrase Study in HIV-1 Naive Patients
Condition: HIV Infections
Intervention: Drug: Raltegravir and Maraviroc in combination
37 Completed Antagonist-Elicited Cannabis Withdrawal
Conditions: Cannabis;   Dependence
Interventions: Drug: THC;   Drug: Rimonobant;   Drug: Rimonabant
38 Completed Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia
Conditions: Schizophrenia;   Psychosis
Intervention:
39 Recruiting Dopamine Function and Reward Processing In Schizophrenia
Condition: Schizophrenia
Intervention:
40 Completed
Has Results
Characteristics of Glargine in Type 2 Diabetics
Condition: Type 2 Diabetes
Intervention: Drug: Placebo or Insulin Glargine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.